Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Biogen Idec Inc (BIIB)  
$215.63 0.71 (0.33%) as of 4:30 Thu 3/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 153,880,000
Market Cap: 33.18(B)
Last Volume: 1,912,268 Avg Vol: 1,347,499
52 Week Range: $216.99 - $318.06
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    : 6.9
Insider 6 Months    : 6.9
Insider 3/6 Months : 14.1
Guru Rank Number :  1040
Guru Rank Value     : -1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Biogen is a biopharmaceutical company focused on discovering, developing and delivering therapies for neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Co. has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA) and Alzheimer's disease. Co. also commercialize biosimilars of biologics and focuses on improving its pipeline in neuroscience and immunology. Co.'s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; ADUHELM for the treatment of Alzheimer's disease; and FUMADERM for the treatment of severe plaque psoriasis.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 455 455 455 455
Total Buy Value $101,256 $101,256 $101,256 $101,256
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 1,423 1,533 5,385 10,995
Total Sell Value $338,133 $365,413 $1,487,360 $3,170,977
Total People Sold 1 1 2 2
Total Sell Transactions 4 5 10 11
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 2104
  Page 1 of 85  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Singhal Priya Head of Development   •       •      –    2024-02-22 4 S $221.23 $57,962 D/D (262) 4,886 3%     
   Kramer Robin Chief Accounting Officer   •       •      –    2024-02-16 4 D $219.08 $86,756 D/D (396) 6,227     -
   Kramer Robin Chief Accounting Officer   •       •      –    2024-02-16 4 OE $0.00 $0 D/D 1,345 6,354     -
   Izzar Rachid Head of Global Product Strat.   •       •      –    2024-02-16 4 D $219.08 $208,564 D/D (952) 9,701     -
   Izzar Rachid Head of Global Product Strat.   •       •      –    2024-02-16 4 OE $0.00 $0 D/D 2,017 10,014     -
   Mcdonnell Michael R EVP, Chief Financial Officer   •       •      –    2024-02-16 4 D $219.08 $753,197 D/D (3,438) 19,406     -
   Mcdonnell Michael R EVP, Chief Financial Officer   •       •      –    2024-02-16 4 OE $0.00 $0 D/D 6,720 20,507     -
   Singhal Priya Head of Development   •       •      –    2024-02-16 4 S $221.49 $23,921 D/D (108) 5,148 1%     
   Singhal Priya Head of Development   •       •      –    2024-02-16 4 D $219.08 $102,529 D/D (468) 5,256     -
   Singhal Priya Head of Development   •       •      –    2024-02-16 4 OE $0.00 $0 D/D 1,208 5,429     -
   Alexander Susan H EVP Chief Legal Officer   •       •      –    2024-02-16 4 D $219.08 $533,898 D/D (2,437) 51,683     -
   Alexander Susan H EVP Chief Legal Officer   •       •      –    2024-02-16 4 OE $0.00 $0 D/D 5,037 52,464     -
   Murphy Nicole Head of Pharm Ops and Tech   •       •      –    2024-02-16 4 D $219.08 $133,639 D/D (610) 9,418     -
   Murphy Nicole Head of Pharm Ops and Tech   •       •      –    2024-02-16 4 OE $0.00 $0 D/D 1,260 9,614     -
   Gregory Ginger EVP, Human Resources   •       •      –    2024-02-16 4 D $219.08 $495,997 D/D (2,264) 13,584     -
   Gregory Ginger EVP, Human Resources   •       •      –    2024-02-16 4 OE $0.00 $0 D/D 4,704 14,313     -
   Rowinsky Eric K Director   •       •      –    2024-02-15 4 B $222.54 $101,256 D/D 455 20,629 2.39 -3%     
   Singhal Priya Head of Development   •       •      –    2024-02-12 4 S $239.45 $100,330 D/D (419) 4,516 12%     
   Mcdonnell Michael R EVP, Chief Financial Officer   •       •      –    2024-02-09 4 D $240.98 $344,842 D/D (1,431) 16,124     -
   Mcdonnell Michael R EVP, Chief Financial Officer   •       •      –    2024-02-09 4 OE $0.00 $0 D/D 3,257 17,555     -
   Izzar Rachid Head of Global Product Strat.   •       •      –    2024-02-09 4 D $240.98 $107,236 D/D (445) 8,636     -
   Izzar Rachid Head of Global Product Strat.   •       •      –    2024-02-09 4 OE $0.00 $0 D/D 1,515 9,081     -
   Gregory Ginger EVP, Human Resources   •       •      –    2024-02-09 4 D $240.98 $152,781 D/D (634) 11,144     -
   Gregory Ginger EVP, Human Resources   •       •      –    2024-02-09 4 OE $0.00 $0 D/D 2,158 11,778     -
   Alexander Susan H EVP Chief Legal Officer   •       •      –    2024-02-09 4 D $240.98 $226,039 D/D (938) 49,083     -

  2104 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 85
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed